Johnson & Johnson (NYSE:JNJ) reported Q2 2025 earnings on July 16, 2025, posting sales of $23.7 billion (up 4.6%), with adjusted EPS of $2.77 and net earnings of $5.5 billion. Management raised ...

Johnson & Johnson ( NYSE: JNJ) Q2 2025 Earnings Conference Call July 16, 2025 8:30 AM ET ...

A study published by Caris showed that certain tumor types had very low or no HER2 overexpression, which has implications for biomarker testing strategies.

Prostate cancer is one of the most common cancers in men in the United States. While one in nine men will be diagnosed with ...

Chemotherapy used to target and kill bladder cancer cells may trigger an inflammatory response that ultimately may make the ...

Discover a study exploring novel drug combinations and genetic insights transforming advanced bladder cancer treatment.

Bladder cancer is among the top 10 most common cancer types in the world, with approximately 573,000 new cases annually. Men ...

Frequent cystoscopy for monitoring nonmuscle-invasive bladder cancer (NMIBC) is burdensome and costly, prompting a search for alternatives.

Bladder cancer symptoms often go unnoticed until it's too late. Learn the warning signs most people ignore and how early ...

The purpose of these estimates is to inform state and local cancer care organizations and providers, patient support programs and educators, advocates, and researchers so they can allocate resources ...

One of the most common early signs of prostate cancer is trouble with urination. Urination is affected because the prostate ...

The Bladder Cancer Advocacy Network (BCAN) today announced a Funding Continuity Grant initiative of up to $1 million to ...